Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056811
Filing Date
2021-11-15
Accepted
2021-11-15 07:48:21
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-10q_20210930.htm   iXBRL 10-Q 2676548
2 EX-10.39 CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT bdsx-ex1039_135.htm EX-10.39 199362
3 EX-31.1 bdsx-ex311_11.htm EX-31.1 21678
4 EX-31.2 bdsx-ex312_8.htm EX-31.2 21695
5 EX-32.1 bdsx-ex321_12.htm EX-32.1 7989
6 EX-32.2 bdsx-ex322_10.htm EX-32.2 8260
  Complete submission text file 0001564590-21-056811.txt   10131086

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20210930.xsd EX-101.SCH 64274
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsx-20210930_cal.xml EX-101.CAL 52168
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsx-20210930_def.xml EX-101.DEF 254153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20210930_lab.xml EX-101.LAB 500634
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20210930_pre.xml EX-101.PRE 408842
12 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-10q_20210930_htm.xml XML 1912316
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 211406384
SIC: 8071 Services-Medical Laboratories